The FDA Wednesday gave emergency approval to a San Diego company’s test for COVID-19 antibodies. Easy Check, from Truvian Sciences, can test for COVID-19 antibodies in under 10 minutes.
Author: HCI
The US Food and Drug Administration has granted separate Emergency Use Authorizations (EUAs) for SARS-CoV-2 antibody tests developed by Access Bio and Truvian Sciences.
Truvian Sciences today announced that the U.S. Food and Drug Administration (FDA) issued Emergency Use Authorization (EUA) for the company’s Easy Check COVID-19 IgM/IgGTM antibody test. Truvian’s Easy Check test is being produced at mass scale at a US based manufacturing facility and will be available to healthcare practitioners immediately.
Managed Healthcare Executive® (MHE) interviewed Jeff Hawkins, president and CEO of Truvian Sciences, about how Truvian received an Emergency Use Authorization (EUA) from FDA for Easy Check COVID-19 IgM/IgG antibody test.